Amp Capital Investors LTD Acadia Pharmaceuticals Inc Transaction History

Amp Capital Investors LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$41.04 - $56.79 $482,343 - $667,452	-11,753 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$36.42 - $57.0 $75,972 - $118,902	2,086 Added 21.58%	11,753 $475,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $84,448 - $113,422	2,151 Added 28.62%	9,667 $466,000
Q1 2020 May 13, 2020	BUY	$31.65 - $46.87 $56,558 - $83,756	1,787 Added 31.19%	7,516 $311,000
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $207,447 - $294,470	5,729 New	5,729 $247,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.